Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Clene Inc (NQ: CLNN ) 5.400 +0.100 (+1.89%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 89,288 Open 5.340 Bid (Size) 5.400 (1) Ask (Size) 5.650 (1) Prev. Close 5.300 Today's Range 5.160 - 5.477 52wk Range 3.818 - 15.57 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Clene Inc.’s (NASDAQ: CLNN) CNM-Au8(R) Affects Key Biomarkers and Long-term Survival in ALS Trials August 22, 2024 Via Investor Brand Network Exposures Product Safety UCSF Team Tests New Drug That Could Reverse Multiple Sclerosis August 19, 2024 Via Investor Brand Network Performance YTD -8.16% -8.16% 1 Month +21.08% +21.08% 3 Month -20.56% -20.56% 6 Month -36.71% -36.71% 1 Year -61.66% -61.66% More News Read More Antioxidants in Seaweed Could Help in Forestalling Parkinson’s Disease August 12, 2024 Via Investor Brand Network Clene Inc.’s (NASDAQ: CLNN) Makes Significant Strides in Developing its Lead Agent, CNM-Au8(R), to Address Neurodegenerative Conditions August 12, 2024 Via Investor Brand Network BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) CEO Spotlighted in Recent BioMedWire Podcast Episode August 08, 2024 Via Investor Brand Network Researchers Identify New Gene Behind ALS Onset July 29, 2024 Via Investor Brand Network BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates August 07, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Submits New CNM-Au8 Biomarker, Clinical Efficacy Data to FDA August 06, 2024 Via Investor Brand Network Exposures Product Safety Clene Inc. (NASDAQ: CLNN) Advances Neurodegenerative Disease Treatment with Innovative Nanotherapeutics August 06, 2024 Via Investor Brand Network BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Participation in Upcoming Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase August 05, 2024 Via Investor Brand Network Clene Inc. (NASDAQ: CLNN) Discusses Important Developments of CNM-Au8(R) and Its Novel Technology During Xtalks Podcast July 26, 2024 Via Investor Brand Network Clene Inc. (NASDAQ: CLNN) Presents Updates on CNM-Au8(R) at Emerging Growth Conference 73 – Biotech Feature July 23, 2024 Via Investor Brand Network Clene Inc. (NASDAQ: CLNN) Announces Plan to Submit Briefing Book to FDA Preceding Type C Interaction July 18, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at the 73rd Emerging Growth Conference July 17, 2024 Via Investor Brand Network Study Suggests Vitamin B Deficiency Could Be Pivotal in Parkinson’s Disease July 15, 2024 Via Investor Brand Network BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Management Slated to Participate in Upcoming Emerging Growth Conference July 12, 2024 Via Investor Brand Network Gold Rises Sharply; Methode Electronics Shares Spike Higher July 11, 2024 Via Benzinga Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 11, 2024 Via Benzinga BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Prepares to Submit Briefing Book to FDA, Looks to Obtain Key Feedback Regarding NDA for CNM-Au8 in ALS July 11, 2024 Via Investor Brand Network Exposures Product Safety Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales July 11, 2024 Via Benzinga S&P 500 Edges Higher; Indivior Shares Plummet July 09, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 09, 2024 Via Benzinga Crude Oil Down 1%; Soligenix Shares Surge July 09, 2024 Via Benzinga Exposures Fossil Fuels BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Effect 1-for-20 Reverse Stock Split July 09, 2024 Via Investor Brand Network Clene Inc. (NASDAQ: CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment July 05, 2024 Via Investor Brand Network Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.